[1]
Gurzhenko, Y. 2021. Study of the Efficiency of Using Type 5 Phosphodiesterase Inhibitors in the Therapy of Ereсtile Dysfunction in Patients with Metabolic Syndrome. Health of Man. 3 (Sep. 2021), 58–69. DOI:https://doi.org/10.30841/2307-5090.3.2021.246211.